Leadership

Program Leaders: Greg Karczmar, PhD, and Aytekin Oto, MD

The University of Chicago Medicine Comprehensive Cancer Center is at the forefront of the developing innovative imaging technologies and analysis approaches that are transforming cancer care.

Extraordinary advances in imaging pioneered by investigators in the Advanced Imaging Program are leading to the ability to diagnose cancer in its early, less harmful stages and attack tumors with greater precision and with less harm to healthy tissue. Imaging is also a crucial element in cancer treatment, as it can be used to assess response to therapy and better deliver cancer therapy, thereby improving effectiveness and reducing off-target effects in normal tissue.

Research in the Advanced Imaging Program ranges from preclinical studies in cells and animal models of cancer, to clinical trials.

Maryellen Giger, PhD, sitting in front of computer
Program member Maryellen Giger, PhD, is internationally known as one of the pioneers of computer-aided diagnosis (CAD).

Key Research Themes

  • Develop novel imaging-based approaches for screening, cancer risk assessment and early detection
  • Improve understanding of cancer biology using imaging, thereby enabling the development of new non-invasive, image-based tumor biomarkers
  • Optimize imaging technologies and approaches for improved treatment response assessment and image-guided therapy
  • Develop new technology for image acquisition and novel data analysis and bioinformatics tools